Related Experiment Video
Updated: Aug 19, 2026

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
[Activating mutations of calcium-sensing receptor cause insufficient secretion of parathyroid hormone]
1Department of Laboratory Medicine, University of Tokyo.
Abstract:
Calcium-sensing receptor (CaSR) was cloned as an essential receptor for regulating secretion of parathyroid hormone (PTH) by extracellular Ca. Sensing of Ca by CaSR activates several intracellular signal transduction systems and suppresses secretion of PTH. Autosomal dominant hypocalcemia (ADH) with insufficient secretion of PTH was shown to be caused by activating mutations of CaSR. Clinical spectrum of ADH is broad from asymptomatic patients to severe hypocalcemia with tetany soon after birth. Some patients formerly believed to have idiopathic hypoparathyroidism may actually have activating mutations of CaSR.
Insights
Activating mutations in the calcium-sensing receptor (CaSR) cause autosomal dominant hypocalcemia (ADH) by disrupting parathyroid hormone (PTH) secretion. This genetic condition presents a wide clinical spectrum, from mild to severe, and may be misdiagnosed as idiopathic hypoparathyroidism.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Context:
- The calcium-sensing receptor (CaSR) plays a crucial role in regulating extracellular calcium levels and parathyroid hormone (PTH) secretion.
- CaSR activation by extracellular calcium triggers intracellular signaling pathways that suppress PTH release.
- Dysregulation of CaSR function is implicated in calcium homeostasis disorders.
Purpose:
- To elucidate the role of the calcium-sensing receptor (CaSR) in the pathogenesis of autosomal dominant hypocalcemia (ADH).
- To investigate the impact of CaSR mutations on parathyroid hormone (PTH) secretion and clinical presentation.
- To differentiate ADH caused by CaSR mutations from other forms of hypoparathyroidism.
Summary:
- Activating mutations in the calcium-sensing receptor (CaSR) gene lead to autosomal dominant hypocalcemia (ADH) due to inappropriately suppressed parathyroid hormone (PTH) secretion.
- These mutations result in a constitutively active CaSR, causing enhanced calcium sensing and reduced PTH release, even at low calcium levels.
- The clinical manifestations of ADH are diverse, ranging from asymptomatic cases to severe neonatal hypocalcemia with tetany, and some cases may be misdiagnosed.
Impact:
- Identifies specific genetic causes for a subset of hypocalcemia patients, enabling more accurate diagnosis.
- Highlights the importance of CaSR genetics in understanding calcium metabolism disorders.
- Potential for improved diagnostic strategies and genetic counseling for families affected by ADH.
Related Concept Videos
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...

